Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03166761 · ClinicalTrials.gov registry record · Phase 4
Particulate Corticosteroid Versus Non-particulate Corticosteroid for Sacroiliac Joint Injection
A Phase 4 study, sponsored by Vanderbilt University Medical Center.
- Terminated
- Registry status
- Phase 4
- Development phase
- 41
- Enrollment target
NCT03166761 is a Phase 4 study that was terminated before completion, run by Vanderbilt University Medical Center. The registered enrollment target is 41 participants.
The verdict
NCT03166761, a Phase 4 study, was terminated before completion, sponsored by Vanderbilt University Medical Center.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 41 participants
- Enrollment target
Study Summary
Comparing two different corticosteroids (dexamethasone and triamcinolone) for use in sacroiliac joint injections
Interventions
- DRUG Dexamethasone
- DRUG Triamcinolone Acetonide
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 41 participants |
| Start Date | 2017-09-14 |
| Est. Completion | 2023-02-28 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03166761
The ClinicalTrials.gov registry entry for NCT03166761 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 41 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt University Medical Center, which has 677 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Dexamethasone is the first listed.
NCT03166761 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03166761 about?
NCT03166761 is a clinical study titled "Particulate Corticosteroid Versus Non-particulate Corticosteroid for Sacroiliac Joint Injection". Comparing two different corticosteroids (dexamethasone and triamcinolone) for use in sacroiliac joint injections
What is the current status of trial NCT03166761?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 41 participants. The study started on 2017-09-14. Estimated completion is 2023-02-28.
What interventions are being tested in trial NCT03166761?
The interventions under investigation include: Dexamethasone (DRUG), Triamcinolone Acetonide (DRUG).
Who is sponsoring clinical trial NCT03166761?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.